REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 82 filers reported holding REVANCE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,699,000 | +30.8% | 516,855 | +2.4% | 0.00% | +100.0% |
| Q3 2016 | $8,178,000 | +16.8% | 504,521 | -2.0% | 0.00% | 0.0% |
| Q2 2016 | $7,003,000 | -18.5% | 514,939 | +4.6% | 0.00% | 0.0% |
| Q1 2016 | $8,597,000 | -42.7% | 492,407 | +12.1% | 0.00% | -50.0% |
| Q4 2015 | $15,010,000 | +72.8% | 439,399 | +50.6% | 0.00% | 0.0% |
| Q3 2015 | $8,684,000 | +33.4% | 291,800 | +43.4% | 0.00% | +100.0% |
| Q2 2015 | $6,508,000 | +217.9% | 203,507 | +106.1% | 0.00% | – |
| Q1 2015 | $2,047,000 | +27.7% | 98,731 | +4.3% | 0.00% | – |
| Q4 2014 | $1,603,000 | -11.9% | 94,622 | +0.5% | 0.00% | – |
| Q3 2014 | $1,820,000 | -55.7% | 94,138 | -22.0% | 0.00% | -100.0% |
| Q2 2014 | $4,104,000 | -14.1% | 120,700 | -20.4% | 0.00% | 0.0% |
| Q1 2014 | $4,775,000 | – | 151,593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |